Laura Papi
University of Florence · 171 works · 11,571 citations · h-index 49
Top works
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
- Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
- Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
- Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
- The neurofibromatosis type 2 gene is inactivated in schwannomas
- Evidence of a four-hit mechanism involvingSMARCB1andNF2in schwannomatosis-associated schwannomas
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
- Microsatellite instability in sporadic mucinous colorectal carcinomas: relationship to clinico-pathological variables
- Identification of six new susceptibility loci for invasive epithelial ovarian cancer
- A new polymorphism in theretprotooncogene (RET)
- Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
- Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
- Prognostic significance of microsatellite instability in sporadic mucinous colorectal cancers
- Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers
- Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
- Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation
- Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas